Get started
Author

Mark L. Fallick

Observed names: M Fallick, M L Fallick, M. Fallick, M.L. FALLICK, MARK L. FALLICK, Mark Fallick
Observed institutions: Tufts University, Tufts Medical Center, Baylor College of Medicine, American Urological Association, Novartis (United States), Myovant Sciences (United States)
OpenAlex ID: A5063808159
Nephrectomy Before Interleukin-2 Therapy for Patients With Metastatic Renal Cell Carcinoma
1997 · Mark L. Fallick, David F. McDermott, et al. · The Journal of Urology · 162
Preliminary Outcomes Following Cryosurgical Ablation of the Prostate in Patients With Clinically Localized Prostate Carcinoma
1998 · John P. Long, Mark L. Fallick, et al. · The Journal of Urology · 84
Varicocelectomy Improves Sperm Strict Morphology and Motility
1998 · EDWARD C. SCHATTE, STEVEN J. HIRSHBERG, et al. · The Journal of Urology · 59
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
2023 · Ronald Tutrone, Fred Saad, et al. · European Urology Oncology · 23
PDF
Metachronous Renal Cell Carcinoma Metastases to Spermatic Cord and Penis
1997 · Mark L. Fallick, John P. Long, et al. · Scandinavian Journal of Urology and Nephrology · 23
Laparoscopic Marsupialization of Lymphocele after Laparoscopic Lymph Node Dissection
1996 · MARK L. FALLICK, JOHN P. LONG · Journal of Endourology · 23
Leydig Cell Tumors Presenting as Azoospermia
1999 · MARK L. FALLICK, WILLIAM W. LIN, et al. · The Journal of Urology · 19
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer
2024 · Daniel E. Spratt, Daniel J. George, et al. · JAMA Oncology · 16
PDF
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer
2023 · Neal D. Shore, Bryan A. Mehlhaff, et al. · Advances in Therapy · 13
PDF
Balanitis xerotica obliterans in monozygotic twins
1997 · M.L. FALLICK, G. FALLER, et al. · British Journal of Urology · 9
Incidence of Cardiovascular Events in Patients With Prostate Cancer and Treated With Androgen Deprivation Therapy
2023 · Benjamin Lowentritt, Mark Fallick, et al. · Urology Practice · 7
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer
2023 · Lindsey Gallagher, Jerry Xiao, et al. · Frontiers in Oncology · 7
PDF
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol
2024 · Daniel E Spratt, Tanya Dorff, et al. · Future Oncology · 6
Collecting-duct carcinoma presenting as upper tract lesion with abnormal urine cytology
1997 · Mark L. Fallick, Martha Hutchinson, et al. · Diagnostic Cytopathology · 6
Real-world treatment patterns and outcomes in advanced prostate cancer: A cohort study using the prostate cancer disease observation (PRECISION) data platform.
2025 · Elisabeth I. Heath, Alton Oliver Sartor, et al. · Journal of Clinical Oncology · 3
PDF
Real-world combination therapy patterns in patients receiving leuprolide or relugolix for androgen deprivation therapy in 2021 (The REAL-ADT COMBO Study): Analysis from a US EMR database.
2023 · Rana R. McKay, Raj Gandhi, et al. · Journal of Clinical Oncology · 3
Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer
2024 · Ashley Ross, Kelsie Brewer, et al. · Advances in Therapy · 2
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with radiation therapy.
2024 · Kelly Gaudian, Min Ji Koh, et al. · Journal of Clinical Oncology · 2
Efficacy and safety of relugolix in black men with advanced prostate cancer: A subgroup analysis from the randomized, phase 3 HERO study versus leuprolide.
2022 · Daniel J. George, Fred Saad, et al. · Journal of Clinical Oncology · 2
Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate.
1997 · J P Long, M L Fallick, et al. · PubMed · 2
Increased Serum Total Creatine Kinase and Creatine Kinase Isoenzyme MB After Cryosurgical Ablation of the Prostate
1997 · John P. Long, Mark L. Fallick, et al. · The Journal of Urology · 2
Common Comorbidities Predict Incidence of Cardiovascular Events in Patients With Prostate Cancer Treated With Androgen Deprivation Therapy
2026 · Paul Sieber, Mark Fallick, et al. · JU Open Plus · 1
Ip26-09 Real-world Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated in Community Urology Centers in the Us: a Cohort Study Using the Precision (prostate Cancer Disease Observation) Data Platform
2025 · Neal D. Shore, Xiao X. Wei, et al. · The Journal of Urology · 1
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer
2025 · Kelly Gaudian, Min Jung Koh, et al. · Frontiers in Oncology · 1
PDF
Pd16-11 Real World Characterization of Patients Receiving Relugolix or Androgen Deprivation Therapy Injections in Combination With Oral Anti-androgens in 2021 (the Real Adt Oral Study): Analysis From a Us Emr Database
2023 · Jason Hafron, Raj Gandhi, et al. · The Journal of Urology · 1
Works count: 44
Citation count: 481
H-index: 9
I10-index: 9
Year
Topic
Type